TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Outcomes of Pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of SAEs Assessed as Related to Triheptanoin Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of All Colon Cancer or Gastrointestinal (GI) Cancer, GI Dysplasia, and GI Neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to peak (TTP) ultrasound measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak intensity (PI) ultrasound measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean transit time (MTT) ultrasound measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gestational diabetes prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of participant falls
Endpoint domain: Adverse events/effects
Primary endpoint: Change in peak plasma concentration of THC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in peak plasma concentration of nicotine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of all immune-related adverse events (irAE)
Endpoint domain: Adverse events/effects
Primary endpoint: SEP-1 bundle compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to final ED disposition order
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Equivalent sphere measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changed risk of renal failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of change in loss of defecation desire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hemoglobin level concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quality of life SF-12 scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of procedures with technical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of procedures without adverse device effects (ADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of Chronic headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in 24-hour ambulatory systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Purpose in Life Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DHE Relative Bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHE Comparative Bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Solicited local & systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: average quantity of Porphyromonas gingivalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial disability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Housebrackmann scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sunnybrook facial grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline at 4 Months: HIV/STI Testing- Self
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change From Baseline at 4 Months: HIV/STI Testing- Partner
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: EVs levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EVs levels in time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Known Adverse Drug Reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Unexpected Adverse Events (AEs)/ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and Risk Factors of Serious Adverse Events (SAEs)/Serious Adverse Drug Reactions (SADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in interference with activities from baseline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Depressive Symptoms from baseline
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concordance of sample collection methods for HPV detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of minimal residual negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieved pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: MOAA/S corresponding to sedation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of ketamine administration
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle Tone and Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forward Jumping Test on One Leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quantity and Frequency of Alcohol Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Alcohol-Related Consequences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant Satisfaction with the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Peak Amplitude of P100, P300, and Late Positive Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Latency of P100, P300, and Late Positive Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Magnitude of Rhythmic Activity in EEG Oscillations: Alpha, Theta, and Delta Bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Subjects with Treatment Emergent Adverse Events (TEAE's)
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed Objective Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Breathing pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in percentage of oral calories
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gait Speed (Single Task) Over 1-minute Walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Neurocognitive Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait Speed (Dual Task {DT}) Over 1-minute Walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyadic Communication Measure for Autism (DCMA)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Percentage of synchronized communication acts with the parents and professionals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Behavior Checklist (CBCL)/1.5-5
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of chronic sacroiliac joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Inspiratory tracheal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Occurrence of clinical relapse at any point in the study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of cannabis use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mental Composite Score (MCS-12)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in state anxiety during stress task anticipation phase
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in state anxiety during stress task performance phase
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Valsalva left ventricular outflow tract gradient (LVOT-G)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with IBD who report clinical levels of anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with IBD who report clinical levels of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of IBD patients who report clinical levels of psychological distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported effort for prenatal notes
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Unaided awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aided awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behaviours relative to diagnosing and managing MASLD
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes of grade of conjunctival hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Schirmer test I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of ocular surface symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cord blood storage decision aid tool effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: T cell generation feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T cell Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Analgesia Nociception Index (ANI) minimum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Hepatocellular Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Laboratory marginal fit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of (serious) adverse events ([S]AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-tumor response: Overall Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Improvement in Frailty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bacterial fecal microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants receiving different treatment regimens
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants who discontinue/switch/add-on treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants who restarted treatment after discontinuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Preparation for Decision Making (PrepDM) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Occurrence of ocular dose limiting events (DLEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of drug-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Suicidal ideation and behavior on PHQ-9M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidal ideation and behavior on CSSRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphagia evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: liver lesion conspicuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious system and procedure-related events
Endpoint domain: Adverse events/effects
Primary endpoint: Chronic isolation of the pulmonary veins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Device Safety as assessed by number of participants with Minor Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Device Safety as assessed by number of participants with Major Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Functional outcome of the Knee Surgery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Phlebotomy- or erythrocytapheresis-free CHR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of confirmed diabetic retinopathy diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Sepsis Early Warning Awareness Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adherence - number of performed exercise sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: retention - number of participants to complete the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Absolute change from baseline in ADAS-Cog-11 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Absolute change from baseline in ADCS-ADL score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Participant Retention Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Immunogenicity of S-RBD IgG antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Perception of Risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of germline genetic testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting-stage fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: IKDC
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of prescribing errors
Endpoint domain: Adverse events/effects
Primary endpoint: asthma-related unplanned emergency department visits
Endpoint domain: Adverse events/effects
Primary endpoint: The Disabilities of the Arm, Shoulder and Hand Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximal Voluntary Isometric Contraction Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single-Leg Triple Hop Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of ΔSVi-AC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported HIV testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linkage to care or prevention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Compliance with AMMA use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Experience of AMMA use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptoms associated with AMMA use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Safety measured by dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in slow oscillation-spindle-hippocampal ripple coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gastric slow waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change from baseline infusion-related reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Patient sickness benefit days per month for LBP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cost of health care per month for LBP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cardiorespiratory exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Biodistribution of [18F]UCB-2897
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of [18F]UCB-2897
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of the MODS recognized system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the MODS recognized system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the MODS recognized system ROC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BGM Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnosis of sleep apnea hypopnea syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VE against hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VE against critical illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VE against outpatient visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VE against UC/ED visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary Arterial Hypertension Symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with hSBA titers more or equal to lower limit of quantification (LLOQ) against each of serogroups A, C, W, and Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titers (GMTs) of Antibodies against Meningococcal Serogroups A, C, W and Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Problems in health care due to COVID-19 related isolation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants with NMOSD attack
Endpoint domain: Adverse events/effects
Primary endpoint: Quantitative Blood Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of participants with reported adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient discomfort during endoscopy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number Of Participants With Treatment-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number Of Dose-limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Change in muscle strength after 2 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in muscle strength after 4 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in muscle strength after 10 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Eating Disorder Examination Questionnaire (EDE-Q) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Eating Disorder Recovery Endorsement Questionnaire (EDREQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Clinical Impairment Assessment (CIA) For Eating Disorders Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of MACE events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: shade matching accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of responses at day 28 post FMT treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations in Default mode network connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of Conversion from iAMD to nGA/iRORA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Conversion from nGA/iRORA to cRORA/GA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Photoreceptor Loss as Assessed by Spectral Domain Optical Coherence Tomography (SD-OCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concentration of specific IgM and IgG antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Experiencing any Dose-limiting Toxicities (DLTs) in Dose-escalation Cohorts
Endpoint domain: Adverse events/effects
Primary endpoint: Comprehensive Complication Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of birth weight lost
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional mobility assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid-related Post-operative nausea and vomiting (PONV)
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid-related sedation
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid-related respiratory depression (RD)
Endpoint domain: Adverse events/effects
Primary endpoint: Asciminib Treatment Persistence Rate Post-Index Date
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: All cause mortality at 30-days
Endpoint domain: Mortality/survival